Sotera Health Company (SHC)
NASDAQ: SHC · IEX Real-Time Price · USD
11.27
-0.11 (-0.97%)
At close: Apr 24, 2024, 4:00 PM
11.69
+0.42 (3.73%)
After-hours: Apr 24, 2024, 6:10 PM EDT
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SHC stock have an average target of 17.7, with a low estimate of 14 and a high estimate of 23. The average target predicts an increase of 57.05% from the current stock price of 11.27.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHC stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 0 | 1 | 1 | 1 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 3 | 4 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $19 → $14 | Buy | Maintains | $19 → $14 | +24.22% | Apr 10, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $18 → $16 | Hold → Strong Buy | Upgrades | $18 → $16 | +41.97% | Apr 3, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $15 → $16 | Hold → Strong Buy | Upgrades | $15 → $16 | +37.53% | Mar 25, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +77.46% | Mar 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +77.46% | Mar 4, 2024 |
Financial Forecast
Revenue This Year
1.11B
from 1.05B
Increased by 5.88%
Revenue Next Year
1.19B
from 1.11B
Increased by 7.02%
EPS This Year
0.72
from 0.18
Increased by 300.63%
EPS Next Year
0.86
from 0.72
Increased by 19.35%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.2B | 1.2B | 1.3B |
| Avg | 1.1B | 1.2B | 1.3B |
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.7% | 12.2% | 12.4% |
| Avg | 5.9% | 7.0% | 7.4% |
| Low | 2.2% | 3.1% | 3.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.76 | 0.98 | 1.11 |
| Avg | 0.72 | 0.86 | 1.03 |
| Low | 0.69 | 0.80 | 0.95 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 320.0% | 35.4% | 29.3% |
| Avg | 300.6% | 19.3% | 19.4% |
| Low | 281.1% | 11.3% | 10.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.